Less than six months ago, the Independent on Sunday published a feature on scientific fraud2. Entitled 'Doctoring the evidence', the article included four case studies illustrating this theme: the vignettes were put in an eyecatching 'box', with the scientists' names in bold type. The first three individuals are British medical doctors Malcolm Pearce, Mark Williams and John Anderton who were struck off the Medical Register for fraud; their nefarious activities also form the backbone of the article itself. The fourth is Dr Thereza Imanishi-Kari, a PhD immunologist in the USA; unlike Pearce, Williams and Anderton, she is not mentioned elsewhere in the text. Moreover, some of the information provided about her is inaccurate, including key details pertaining to the investigation of her alleged misconduct. However, readers are correctly informed that she was 'for almost a decade, at the centre of America's most notorious alleged [scientific] fraud cause'. In palpably grudging tones the journalist finally reveals that Imanishi-Kari was ultimately cleared of charges of misconductalmost as though even now he cannot quite bring himself to acknowledge her innocence.
Daniel J Kevles, historian and author of The Baltimore Case3, shows no such reservation. He nails his colours to the mast in the preface, where he explains not only how he came to believe that Imanishi-Kari was innocent before her exoneration (he said as much in an article in the New Yorker) but also why the case highlights the civil rights of scientists charged with fraud. As Kevles has subsequently summar-ized4 during Imanishi-Kari's relentless hounding by assorted committees, she was 'denied elementary protections of due process, especially the right to see and evaluate evidence and the right to confront and cross-examine witnesses against her'. Her dogged determination and that of her supporters ultimately gained her access to an appeals board, where she was afforded these fundamental rights. That researchers accused of wrongdoing should be granted access to an appeals procedure is now generally accepted; this was not so before Imanishi-Kari's ordeal. Clearly scientists everywhere have good reason to be grateful for her tenacity.
Kevles' book is a gripping detective story that centres on a disputed article published in Cell in 1986. His mastery of fundamental immunological details and the general process of scientific research is impressive. He needed to master them to fully understand the claims and counter-claims that mark the saga, something that many of Imanishi-Kari's accusers, in committee working as well as the media, signally failed to do. It was dubbed the Baltimore case almost from the beginning, after David Baltimore, the Nobel laureate who was a co-author of the Cell paper5. The research largely emanated from the Massachusetts Institute of Technology (MIT), where Baltimore and Imanishi-Kari both worked, although Imanishi-Kari was about to move to Tufts.
Imanishi-Kari's laboratory at MIT included students, junior scientists, a technician (Albanese), and a visiting scientist from Brazil (Reis). Weaver was a post-doctoral fellow of Baltimore's and Constantini worked at Columbia University in New York. In the summer of 1985, before publication of the Cell paper, Dr Margot O'Toole joined Imanishi-Kari on a one-year post-doctoral fellowship funded by the National Institutes of Health (NIH); she was to do some experiments to extend the work that lay behind the Cell article. Kevles relates that O'Toole's unhappiness at not being able to get the results she sought led to the first complaint about Imanishi-Kari's Cell data. From then on, O'Toole seemed destined to embrace her role as whistleblower extraordinaire. Underlying everything was a personality clash that was apparent to many virtually from the outset-Imanishi-Kari, the established scientist, born in Brazil to Japanese parents, described by an immunologist friend as intense and with high expectations yet somewhat careless in her record keeping, with an imperfect command of English, versus O'Toole, the highly articulate junior researcher, whose family, characterized by a 'propensity for dissent' according to Kevles, moved from Dublin to Boston when she was a teenager. Her previous laboratory chief at Fox Chase Cancer Research Center, Philadelphia, recalls that O'Toole 'had an instinct for polarizing laboratory members over minor issues'; she herself describes a scientific argument with Imanishi-Kari on her first day at MIT.
During the harrowing ten years that followed, the disputed Cell data were scrutinized by an informal Tufts inquiry, by an MIT review, by an NIH panel, by a Congressional subcommittee led by John Dingell, by the Office of Scientific Integrity (OSI, run by NIH), and finally by OSI's successor, the Office of Research Integrity (ORI). Key players in this protracted affair included the 'fraudbusters' Ned Feder and Walter W Steward, NIH staff scientists who essentially abandoned their science to run a two-man fraud squad from their lab, and Secret Service document analysts. O'Toole's complaints progressed from Qr0 0 654 error (yet she would not write a letter to Cell setting out her arguments) to fraud.
O'Toole is clearly a persuasive and engaging individual; the force of her personality shines through the book. Kevles, on first meeting her in 1992, says 'she held me in thrall for hours'. While Imanishi-Kari acknowledged some carelessness in the disputed paper, O'Toole became convinced there was fabrication, and she acquired an impressive array of supporters, some for the flimsiest of reasons. James Watson had never met O'Toole yet nevertheless believed 'that good Irish girl' [her testimony to MIT]; he commented subsequently that his mother was Irish. Imanishi-Kari's lawyer remarked with some feeling that the pursuit of his client had all the classic trappings of a witch hunt; others referred to McCarthyism. Thus, O'Toole was asked by Brian Kimes, Acting Director of OSI, to index Imanishi-Kari's laboratory notebooks and was involved in almost every step of the OSI investigation, while Imanishi-Kari was denied access to the evidence being amassed against her. Then there was Suzanne Hadley, the clinical psychologist who progressed from Deputy Director to Director of OSI in November 1989; on leaving OSI she became associated with the Dingell subcommittee, obtained documents from OSI staff, and subsequently went to work for Dingell. As Kevles put it, she was obsessed with the notion of guilty until proven innocent.
The draft OSI report, finalized by Hadley's team in March 1991 and promptly leaked via Steward and Feder, included some gross factual errors, such as the claim that O'Toole was dismissed from MIT when in fact her grant had run out, and there was no mention in the index of the minority opinions of two committee members who disagreed with its conclusion that Imanishi-Kari was guilty of fraud. Baltimore, as a result of the OSI report, formally retracted the Cell paper, but cancelled the retraction when the Secret Service analysis was discredited. Overall he stood by Imanishi-Kari, at considerable personal cost e.g. having been appointed President of Rockefeller University in 1990 he resigned 18 months later, citing pressure from colleagues and the toll of fighting the battle over the Cell paper.
In June 1992, OSI was taken away from NIH and reconstituted as ORI under the aegis of the Department of Health and Human Services. For the first time the process of investigation included an appeals procedure. The ORI report (1994) also pronounced Imanishi-Kari guilty; it was only when the case proceeded to appeal (a process that generated 6500 pages of transcript) that Imanishi-Kari was given a fair hearing. The appeal panel, in a verdict released on 21 June 1996, exonerated her on all 19 ORI charges. Dylan Thomas dedicated This Side of the Truth' to his elder son. As a teenager already writing poetry of considerable potential, he put his name to two poems he had shamelessly copied; one was spotted before its intended publication in his school magazine but the other appeared in the Western Mail and was only identified as a case of blatant plagiarism 20 years after Thomas's death. His reputation as a writer appears unsullied by such misconduct; Imanishi-Kari's reputation as a scientist remains tainted, although she was cleared of wrongdoing. As she continues with her career, she must wonder why her side of the truth remained unheard for so long. Imogen Evans Little Orchard, Scotsford Road, Broad Oak, Heathfield, East Sussex TN21 8UD, UK
